Boston, MA (PRWEB) April 08, 2013
David J. Dykeman, co-chair of Greenberg Traurig’s Intellectual Property Department in the Boston office, will serve as event co-chair and presenter at BIOMEDevice 2013 Boston, April 10-11, 2013 at the Boston Convention Center. Thomas Sommer, President of the Massachusetts Medical Device Industry Council (MassMEDIC) is Dykeman’s conference co-chair.
As a featured conference speaker, Dykeman will present “Patent Reform Reinvents Medtech Innovation" on Wednesday, April 10th from 3:15 - 3:45 pm with fellow Greenberg Traurig patent attorney, Roman Fayerberg. The presentation will explore the legal and industry issues impacting how medical device and life science companies develop and manage their patent portfolios, secure funding, and achieve growth. Among the topics Dykeman and Fayerberg will address include:
-Changes to the patent system as presented by the landmark America Invents Act
-Efficiently integrating patent strategy into product development
-US Supreme Court’s issuance of far-reaching patent opinions, including the recent decisions: Mayo v. Prometheus Laboratories, Bilski v. Kappos, and Association for Molecular
Pathology v. USPTO and Myriad Genetics
A registered patent attorney with over 16 years of experience in patents, intellectual property, and licensing, Dykeman’s practice focuses on securing strategic worldwide intellectual property protection and related business strategy for high-tech clients, with particular expertise in medical devices, life sciences, biotechnology and healthcare IT. Dykeman serves on the Board of Directors of the Massachusetts Medical Device Industry Council (MassMEDIC), and on the Editorial Advisory Board of Medical Device + Diagnostic Industry (MD+DI) Magazine. He was appointed the founding Co-Chair of the ABA Section of Science & Technology Law's Medical Device Committee and serves on the Massachusetts Life Sciences Collaborative Research, Innovation & Commercialization Task Force.
An author of over 35 articles and a speaker at over 35 conferences on medical devices and life sciences intellectual property, Dykeman was honored as a one of the “40 Medtech Innovator Under 40” by MD+DI magazine, and was named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine.
Fayerberg focuses his practice on preparation and prosecution of patent applications and counseling clients on patent issues, primarily in technologies related to medical devices, drug delivery systems, biodegradable polymers and pharmaceutical formulations. His patent practice builds on seven years of experience he gained as a research and development engineer at C.R. Bard, where he developed biomaterials-based products for hemostasis and soft tissue reconstruction and designed manufacturing equipment for these products, and Boston Scientific Corporation, where he designed and developed new products for less invasive neurosurgery, such as catheters, stents, and stent delivery systems.
About BIOMEDevice 2013 Boston
BIOMEDevice 2013 Boston is aimed at medical device manufacturing professionals. It features targeted networking and educational sessions led by top med-tech innovators and medical device Original Equipment Manufacturers (OEMs) to inspire next-generation medical devices and offer practical solutions through each stage of the design and development process. Leading OEMs, industry experts, and top innovators will deliver practical presentations and implementable solutions to engineers, R&D, design and manufacturing professionals in the medical device sector. BIOMEDevice 2013 Boston allows attendees to network, meet face-to-face with industry experts, and take away practical insights into the most cutting-edge technologies and trends driving the next generation of device development. To register, please visit http://www.canontradeshows.com/expo/bioboston13/index.html.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, full-service law firm with approximately 1750 attorneys serving clients from 36 offices in the United States, Latin America, Europe, the Middle East and Asia. In the U.S., the firm has more offices than any other among the Top 10 on The National Law Journal's 2012 NLJ 250. For additional information, please visit http://www.gtlaw.com.